U.S. federal trademark · Serial No. 86035049 · Reg. No. 4517481
Providing personalized healthcare and medical information, namely, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate drug and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing and bioinformatics analysis, and consultation services related thereto; medical testing services, namely, providing medical tests that measure, analyze and interpret genes of patients, environmental, and other factors to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment options and choices for patients, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients; providing medical information to patients and medical professionals in the form of reports for the foregoing medical testing services
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.